NCT06964399

Brief Summary

In this study titled "Psychological Well-Being and Awareness in the Elderly: The Effect of Reminiscence Therapy", patients will be randomly divided into two groups as experimental and control groups. No intervention will be made to the patients in the control group. Reminiscence therapy will be applied to the patients in the experimental group. Participants will be asked to fill out the scale forms after accepting to participate in the study and obtaining their consent. In addition, after the reminiscence therapy is completed, the experimental and control groups will be asked to fill out the post-test forms. The following questions will be answered in the study;

  • Does reminiscence therapy affect the psychological well-being levels of the elderly?
  • Does reminiscence therapy affect the awareness levels of the elderly?

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2025

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

April 24, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

May 9, 2025

Completed
21 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

May 9, 2025

Status Verified

April 1, 2025

Enrollment Period

2 months

First QC Date

April 24, 2025

Last Update Submit

May 7, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Psychological well-being Scale

    scale score average, It is a single-factor scale consisting of 8 items on a 7-point Likert type. Scores range from 8 to 56. A high score obtained from the scale indicates that the person has many psychological resources and strengths.

    1 months

Study Arms (2)

Experimental Group

EXPERIMENTAL

Reminiscence Therapy can be applied as 1 or 2 sessions per week and the longest is 1.5 hours, so it will be applied for 5 weeks, 3 days a week (Monday, Wednesday, Friday) with 2 sessions per day. Each session is planned to last an average of 1.5 hours according to the answers from the elderly. The elderly individuals in the experimental group will be divided into 3 groups. Each group will consist of 15 people. The sessions will include, respectively, getting to know each other, childhood, places lived, holidays-festivals, foods-cooking, unforgettable historical periods, favorite music, movies specific to the period, family life-values in life-achievements, evaluation and closing topics.

Other: Reminiscence therapy

Control Group

NO INTERVENTION

There will be no intervention in the control group during the research process.

Interventions

Reminiscence Therapy can be applied as 1 or 2 sessions per week and the longest is 1.5 hours, so it will be applied for 5 weeks, 3 days a week (Monday, Wednesday, Friday) with 2 sessions per day. Each session is planned to last an average of 1.5 hours according to the answers from the elderly. The elderly individuals in the experimental group will be divided into 3 groups. Each group will consist of 15 people. The sessions will include, respectively, getting to know each other, childhood, places lived, holidays-festivals, foods-cooking, unforgettable historical periods, favorite music, movies specific to the period, family life-values in life-achievements, evaluation and closing topics.

Experimental Group

Eligibility Criteria

Age65 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Being over 65 years old
  • not having any serious psychiatric disorders
  • not having any diseases such as dementia etc.

You may not qualify if:

  • Having a serious psychiatric disorder
  • Not being able to attend sessions during the research process

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ağın Community Health Center

Elâzığ, 23960, Turkey (Türkiye)

RECRUITING

Study Officials

  • Güzel Nur YILDIZ, Dr

    Muş Alparslan University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Meltem ÇAPAR, Specialist

CONTACT

Meltem Çapar, Specialst

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 24, 2025

First Posted

May 9, 2025

Study Start

April 1, 2025

Primary Completion

May 30, 2025

Study Completion

June 30, 2025

Last Updated

May 9, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations